Ceftriaxone 250, 500 And 1 000 Pharma-Q 250, 500 and 1 000 mg/via Sterile powder for injection.
PDF Leaflet Revision Date: 08 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of various bacterial infections.
Dosage (summary)
Adults: 1-2 g once daily; severe cases: up to 4 g once daily.
Special Populations
- Elderly
- Neonates
- Impaired renal function
- Impaired hepatic function
Pregnancy & Breastfeeding
Crosses placenta; limited data in pregnancy; excreted in breast milk, caution advised.
Key Drug Interactions
- Calcium-containing products
- Oral anticoagulants
- Aminoglycosides
Contraindications
- Hypersensitivity to ceftriaxone
- Severe hypersensitivity to beta-lactams
- Premature neonates
- Full-term neonates with hyperbilirubinaemia
Common side effects
- Eosinophilia
- Leukopenia
- Thrombocytopenia
- Diarrhoea
- Rash
Counselling Points
- Report any allergic reactions
- Monitor for signs of superinfection
- Avoid mixing with calcium solutions
Serious warnings
- Serious hypersensitivity reactions
- Severe cutaneous adverse reactions
- Risk of precipitation with calcium
Important Disclaimer
The Ceftriaxone 250, 500 And 1 000 Pharma-Q 250, 500 and 1 000 mg/via Sterile powder for injection. professional information leaflet below is the property of Pharma-Q and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
